We are live on ! Find out more
MEDS

DataMeds AI
MEDS

6 hedge funds and large institutions have $593K invested in DataMeds AI in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

20% more funds holding

Funds holding: 5 → 6 (+1)

0.36% more ownership

Funds ownership: 0.49% → 0.85% (+0.36%)

61% less capital invested

Capital invested by funds: $1.53M → $593K (-$935K)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$963K
2
Renaissance Technologies
Renaissance Technologies
New York
+$28.1K
3
Raymond James Financial
Raymond James Financial
Florida
+$23.2K
4
Osaic Holdings
Osaic Holdings
Arizona
+$2.76K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$336K
2
Citadel Advisors
Citadel Advisors
Florida
-$129K
3
UBS Group
UBS Group
Switzerland
-$12.8K

MEDS Hedge Fund Activity: Q2 2025 in Review

6 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in DataMeds AI (MEDS) for Q2 2025, worth a combined $593K — down 61% from $1.53M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new MEDS positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Millennium Management, adding an estimated $963K. The largest seller was HRT Financial, exiting entirely with an estimated $336K sold.

  • 6 institutional investors held DataMeds AI (MEDS) as of Q2 2025, up from 5 in Q1 2025.
  • Funds reported $593K of DataMeds AI stock for Q2 2025, down 61% quarter-over-quarter.
  • 4 funds opened new DataMeds AI positions in Q2 2025 and 3 closed out, a net change of +1 holder.
  • The largest DataMeds AI buyer in Q2 2025 was Millennium Management, an estimated $963K added.
  • The largest DataMeds AI seller in Q2 2025 was HRT Financial, an estimated $336K sold.

Based on aggregated 13F filings for Q2 2025.